Perrigo
Headquartered in Ireland, Perrigo Company plc is a global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements, active pharmaceutical ingredients (API), and medical diagnostic products and receives royalties from Multiple Sclerosis drug Tysabri.
In 2013 it acquired Irish pharma company Elan.
Financial Data
-
31st Dec 21 Source: CRO
- €3.7 billion turnover
-
€228.4 million
profit - 11,500 employees
-
31st Dec 20 Source: CRO
- €4.1 billion turnover
-
-€121.6 million
profit - 11,500 employees
- 7 more years available »
Ranking
By Turnover
(€3.7 billion)- 37th in Top Companies
- 8th in Health
- 5th in Pharma
By Employees
(11,500)- 19th in Top Companies
- 4th in Health
- 2nd in Pharma
-
- 11,500
- €3.7 billion
Employees
- Murray S. Kessler CEO/Managing Director
Latest News
- May 24 Harsh winter may compel Europe to ration gas, warns International Energy Agency
- May 24 Hungary and Poland hold up EU decisions on oil and corporate tax
- May 24 Over 700 objections lodged against €466m Dundrum apartment ‘concrete jungle’
- May 24 Stripe unveils new third party app marketplace
- May 24 Shares in UK energy companies slide over windfall tax fears